...
首页> 外文期刊>Scientific reports. >Development of passive CLARITY and immunofluorescent labelling of multiple proteins in human cerebellum: understanding mechanisms of neurodegeneration in mitochondrial disease
【24h】

Development of passive CLARITY and immunofluorescent labelling of multiple proteins in human cerebellum: understanding mechanisms of neurodegeneration in mitochondrial disease

机译:人床多种蛋白质的被动透明度和免疫荧光标记的研制:了解线粒体疾病神经变性的理解机制

获取原文

摘要

CLARITY enables immunofluorescent labelling and imaging of large volumes of tissue to provide a better insight into the three dimensional relationship between cellular morphology and spatial interactions between different cell types. In the current study, we optimise passive CLARITY and immunofluorescent labelling of neurons and mitochondrial proteins in mouse and human brain tissues to gain further insights into mechanisms of neurodegeneration occurring in mitochondrial disease. This is the first study to utilise human cerebellum fixed in paraformaldehyde and cryoprotected in conjunction with formalin-fixed tissues opening up further avenues for use of archived tissue. We optimised hydrogel-embedding and passive clearance of lipids from both mouse (n?=?5) and human (n?=?9) cerebellum as well as developing an immunofluorescent protocol that consistently labels different neuronal domains as well as blood vessels. In addition to visualising large structures, we were able to visualise mitochondrial proteins in passively cleared tissues to reveal respiratory chain deficiency associated with mitochondrial disease. We also demonstrate multiple use of tissues by stripping antibodies and re-probing the cerebellum. This technique allows interrogation of large volumes intact brain samples for better understanding of the complex pathological changes taking place in mitochondrial disease.
机译:清晰度使大量组织的免疫荧光标记和成像能够更好地了解细胞形态与不同细胞类型之间的三维关系的三维关系。在目前的研究中,我们优化了小鼠和人脑组织中神经元和线粒体蛋白的被动清晰度和免疫荧光标记,进一步了解线粒体疾病中发生神经变性机制的洞察力。这是第一项研究,用于利用多甲醛固定在多聚甲醛中的人类小脑,并与福尔马林固定组织一起冷冻保护,从而开放进一步的途径以使用存档的组织。我们优化了从小鼠(N?=β5)和人(N?=β5)和人(n?=β9)的脂质的水凝胶嵌入和被动清除,以及显影免疫荧光方案,始终标记不同的神经元域以及血管。除了可视化大结构之外,我们还能够在被动清除组织中可视化线粒体蛋白,以揭示与线粒体疾病相关的呼吸链缺乏。我们还通过剥离抗体并重新探测小脑来证明多次使用组织。该技术允许询问大量完整的脑样本,以便更好地了解线粒体疾病中发生的复杂病理变化。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号